Develops improved diagnostic platforms in SARS-CoV-2, indicating potential for advanced therapeutics.
values below 4 μg/mL. These findings highlight the potential utility of these scFvs as candidate reagents for the development of improved diagnostic platforms and as scaffolds for next-generation monoclonal antibody-based therapeutics.
No takes yet. Share an insight, caveat, or question.
Alam et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: